{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:15:20Z","timestamp":1788120920780,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier","isbn-type":[{"value":"9780443297229","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.04.016","type":"book-chapter","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:12:23Z","timestamp":1746789143000},"page":"191-197","source":"Crossref","is-referenced-by-count":1,"title":["Future perspectives on myasthenia gravis and related disorders"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.irn.2025.04.016_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-025-08096-9","article-title":"Efgartigimod improves non-AChR generalized myasthenia gravis: A real world experience","author":"Antozzi","year":"2025","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.016_bib2","doi-asserted-by":"crossref","DOI":"10.17161\/rrnmf.v4i3.19553","article-title":"Challenges managing myasthenia gravis: An international perspective","volume":"4","author":"Barnett","year":"2023","journal-title":"RRNMF Neuromuscular Journal"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.016_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/mus.26695","article-title":"Cross-sectional analysis of the myasthenia gravis patient registry: Disability and treatment","volume":"60","author":"Cutter","year":"2019","journal-title":"Muscle & Nerve"},{"key":"10.1016\/bs.irn.2025.04.016_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2024.104468","article-title":"275th ENMC international workshop: Seronegative myasthenia gravis: An update paradigm for diagnosis and management, 9-11 February 2024, Hoofddorp, the Netherlands","volume":"44","author":"Evoli","year":"2024","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.016_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00401-020-02147-5","article-title":"Complement deposition at the neuromuscular junction in seronegative myasthenia gravis","volume":"139","author":"Hoffmann","year":"2020","journal-title":"Acta Neuropathologica"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.016_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.538","article-title":"Fatigue in myasthenia gravis: Risk factors and impact on quality of life","volume":"6","author":"Hoffmann","year":"2016","journal-title":"Brain and Behavior"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.016_bib7","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.clinph.2014.06.031","article-title":"Lambert-Eaton myasthenic syndrome diagnosis, pathogenesis and therapy","volume":"125","author":"H\u00fclsbrink","year":"2014","journal-title":"Clinical Neurophysiology"},{"key":"10.1016\/bs.irn.2025.04.016_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241309431","article-title":"Eculizumab in thymoma-associated myasthenia gravis: A real-world cohort study","volume":"17","author":"Jin","year":"2024","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"10.1016\/bs.irn.2025.04.016_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1472845","article-title":"Efgartigimod treatment for generalized myasthenia gravis: A single-center case series of 16 patients","volume":"15","author":"Nomura","year":"2024","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.016_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40801-024-00457-8","article-title":"ELEVATE study group. US clinical practice experience with Eculizumab in myasthenia gravis: Acute clinical events and healthcare resource utilization","volume":"11","author":"Nowak","year":"2024","journal-title":"Drugs Real World Outcomes"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.016_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.nmd.2020.06.010","article-title":"Fatigue in patients with myasthenia gravis. A systematic review of the literature","volume":"30","author":"Ruiter","year":"2020","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.016_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/CND.0000000000000239","article-title":"Amifampridine phosphate (Firdapse) is effective in a confirmatory phase 3 clinical trial in LEMS","volume":"20","author":"Shieh","year":"2019","journal-title":"Journal of Clinical Neuromuscular Disease"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.016_bib13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Lambert-Eaton myasthenic syndrome: From clinical characteristics to therapeutic strategies","volume":"10","author":"Titulaer","year":"2011","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.016_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/mus.26069","article-title":"Fatigue is a relevant outcome in patients with myasthenia gravis","volume":"58","author":"Tran","year":"2018","journal-title":"Muscle & Nerve"},{"key":"10.1016\/bs.irn.2025.04.016_bib15","series-title":"Eculizumab and efgartigamod for the treatment of myasthenia gravis: Effectiveness and value; final report","author":"Trice","year":"2021"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.016_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12883-023-03406-0","article-title":"Female sex and overweight are associated with a lower quality of life in patients with myasthenia gravis: A single center cohort study","volume":"23","author":"Wilcke","year":"2023","journal-title":"BMC Neurology"}],"container-title":["International Review of Neurobiology","Myasthenia Gravis, Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T03:57:57Z","timestamp":1760500677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443297229"],"references-count":16,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.04.016","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}